Evidence map›Paper›PMID 23011115›Full record

ArticleRegional anesthesia and pain medicine

In Zucker diabetic fatty rats, subclinical diabetic neuropathy increases in vivo lidocaine block duration but not in vitro neurotoxicity.

Philipp Lirk, Magdalena Flatz, Ingrid Haller, Barbara Hausott, Stephan Blumenthal, Markus F Stevens, Suzuko Suzuki, Lars Klimaschewski, Peter Gerner

Open access · greenAbstract read
In one paragraph

Article in Regional anesthesia and pain medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Alternatives to the Streptozotocin-Diabetic Rodent.International review of neurobiology · 2016
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Philipp LirkDepartment of Anesthesiology, Academic Medical Center, University of Amsterdam, the Netherlands. p.lirk@amc.uva.nl
Magdalena Flatz
Ingrid Haller
Barbara Hausott
Stephan Blumenthal
Markus F Stevens
Suzuko Suzuki
Lars Klimaschewski
Peter Gerner
Brigham and Women's Hospital · USInnsbruck Medical University · ATAcademic Medical Center · NLTriemli Hospital · CHUniversity of Amsterdam · NL

Funding

Development of Sensory/Pain-Selective Local AnestheticsK08GM064051 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI GERNER, PETER · 2002 to 2006
$641k
NIGMS NIH HHS GM64051NIGMS NIH HHS K08 GM064051
6 · The paper itself

Abstract

BACKGROUND AND

objectivesApplication of local anesthetics may lead to nerve damage. Increasing evidence suggests that risk of neurotoxicity is higher in patients with diabetic peripheral neuropathy. In addition, block duration may be prolonged in neuropathy. We sought to investigate neurotoxicity in vitro and block duration in vivo in a genetic animal model of diabetes mellitus type 2.

methodsIn the first experiments, neurons harvested from control Zucker diabetic fatty (ZDF) rats were exposed to acute (24 hours) or chronic (72 hours) hyperglycemia, followed by incubation with lidocaine 40 mM (approximately 1%). In a second experiment, neurons harvested from control ZDF rats, or diabetic ZDF rats, were incubated with lidocaine, with or without SB203580, an inhibitor of the p38 mitogen-activated protein kinase. Finally, we performed sciatic nerve block (lidocaine 2%, 0.2 mL) in control or diabetic ZDF rats and measured motor and nociceptive block duration.

resultsIn vitro, neither acute nor chronic hyperglycemia altered neurotoxic properties of lidocaine. In vitro, incubation of neurons with lidocaine resulted in a slightly decreased survival ratio when neurons were harvested from diabetic (57% ± 19%) as compared with control (64% ± 9%) rats. The addition of SB203580 partly reversed this enhanced neurotoxic effect and raised survival to 71% ± 12% in diabetic neurons and 66% ± 9% in control rats, respectively. In vivo, even though no difference was detected at baseline testing, motor block was significantly prolonged in diabetic as compared with control rats (137 ± 16 vs 86 ± 17 min).

conclusionsIn vitro, local anesthetic neurotoxicity was more pronounced on neurons from diabetic animals, but the survival difference was small. In vivo, subclinical neuropathy leads to substantial prolongation of block duration. We conclude that early diabetic neuropathy increases block duration, whereas the observed increase in toxicity was small.

Indexed as

Nerve BlockAnesthetics, LocalAnimalsBehavior, AnimalCell CountCells, CulturedCell SurvivalDiabetes Mellitus, Type 2Diabetic NeuropathiesEnzyme InhibitorsImidazolesLidocaineL-Lactate DehydrogenaseMaleNeuronsNociceptionAnesthetics, LocalEnzyme InhibitorsImidazolesLidocaineL-Lactate Dehydrogenasep38 Mitogen-Activated Protein KinasesPyridinesSB 203580

Identifiers

PMID23011115
PMCPMC3480545
OpenAlexW2091158172

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.